At Magellan, our job is to provide pharmaceutical development services that take your new drug to market easier and faster – something our proven industry experts know quite a bit about. Magellan is a truly unique pharmaceutical development organization in that each member of its staff is selected upon proven pharmaceutical experience and unsurpassed expertise within their field.

Magellan's corporate structure is designed to provide independent checks and balances to ensure clients receive quality, timely data and reports. The Pharmaceutical Development branch, led by W. Lowry Caudill, Ph.D., performs the full-range of contract services, while the Administrative branch, led by Alfred G. Childers, Ph.D., independently audits the work performed to ensure the services are compliant and of high quality.

Magellan top management:

	Alfred G. Childers, Ph.D. President Administration	W. Lowry Caudill, Ph.D. President Pharmaceutical Development
	Richard Kenley, Ph.D.	Executive Vice President General Manager Biotechnology Facility
	William Stagner, Ph.D.	Senior Vice President General Manager Somerset Facility
	Robert Woodhouse, Ph.D.	Senior Vice President General Manager Research Triangle Park Facility
	Bruce Boucher	Senior Vice President Chief Financial Officer
	Bob Bergstrom, Ph.D.	Vice President Biotechnology Facility
	Tony Chilton, Ph.D.	Vice President Research & Bioanalytical
	Lori Feehan	Vice President Commercial Development
	Eric Hoffman	Vice President Business Development
	Ted Williams	Executive Director Human Resources